The current race to find anti-viral treatments for COVID-19 and an effective vaccine for SARS-CoV-2, have brought into focus the utility of the Text and Data Mining of scientific content, together with AI supported methods, to greatly reduce the time needed to accurately identify candidate solutions. Springer Nature is now collaborating with a variety of partners to provide free access to the relevant content for both human and machine consumption and you can now gain direct free access to the content by registering for an API key to gain free access to the Fulltext XML of all our relevant Springer and Nature Journal content to support you in your COVID-19 efforts. Request your API key now: https://www.springernature.com/gp/campaign/librarian-covid-tdm.
Springer Nature is a Purchasing Consortium Member – members of MassBio with under 99 R&D staff members receive exclusive discounts, click here if you are interested in having unlimited access to research journals or ebooks from Springer Nature (or feel free to contact Caitlin Cricco at caitlin.cricco@springernature.com).